-
CTL IP Series 2: What is Patent Eligible in the U.S.?
CTL IP Series 2: What is Patent Eligible in the U.S.?
For this second virtual meeting of the IP series, Dr. John D. Lopinski, Partner at Hodgson Russ LLP, will present an overview of patent eligible subject matter and will provide some examples to illustrate issues related to patent eligibility.
Dr. John D. Lopinski will be joined by Bill Pegg, Associate Director for IP at CTL.
Topics includes:
- Overview of patent eligible subject matter
- Challenges in obtaining patent eligibility in Life Sciences (e.g., Diagnostics, Antibodies, etc.)
- Challenges in obtaining patent eligibility in Physical Sciences (e.g., Electronics, Encryption, Blockchain, Crypto, Software, etc.)
